nach oben

Journal of Medical Systems

Erschienen in:

01.02.2017 | Systems-Level Quality Improvement

Incorporating Pharmacogenomics into Health Information Technology, Electronic Health Record and Decision Support System: An Overview

verfasst von: Abdullah Alanazi

Erschienen in: Journal of Medical Systems | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

As the adoption of information technology in healthcare is rising, the potentiality of moving Pharmacogenomics from benchside to bedside is aggravated. This paper reviews the current status of Pharmacogenomics (PGx) information and the attempts for incorporating them into the Electronic Health Record (EHR) system through Decision Support Systems (DSSs). Rigorous review strategies of PGx information and providing context-relevant recommendations in form of action plan- dose adjustment, lab tests rather than just information- would be ideal for making clinical recommendations out of PGx information. Lastly, realistic projections of what pharmacogenomics can provide is another important aspect in incorporating Pharmacogenomics into health information technology.

Wilkinson, G. R., Drug metabolism and variability among patients in drug response. N. Engl. J. Med. 352(21):2211–2221, 2005.CrossRefPubMed

Roden, D. M., and George, A. L., Jr., The genetic basis of variability in drug responses. Nat. Rev. Drug Discov. 1(1):37–44, 2002.CrossRefPubMed

Exner, D. V., Dries, D. L., Domanski, M. J., and Cohn, J. N., Lesser response to angiotensin-converting–enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N. Engl. J. Med. 344(18):1351–1357, 2001.CrossRefPubMed

Taylor, A. L., Ziesche, S., Yancy, C., Carson, P., D’Agostino, R., Jr., Ferdinand, K., Worcel, M., et al., Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N. Engl. J. Med. 351(20):2049–2057, 2004.CrossRefPubMed

Ma, Q., and Lu, A. Y. H., Pharmacogenetics, pharmacogenomics, and individualized medicine. Pharmacol. Rev. 63(2):437–459, 2011.CrossRefPubMed

Watson, J. D., and Crick, F. H., Molecular structure of nucleic acids: A structure for deoxyribose nucleic acid. Nature 171(4356):737–738, 1953. doi:10.1038/171737a0.CrossRefPubMed

Meyer, U. A., Timeline: Pharmacogenetics – five decades of therapeutic lessons from genetic diversity. Nat. Rev. Genet. 5(9):669–676, 2004. doi:10.1038/nrg1428.CrossRefPubMed

Ma, J. D., Lee, K. C., and Kuo, G. M., Clinical application of pharmacogenomics. J. Pharm. Pract. 25(4):417–427, 2012.CrossRefPubMed

Shi, M. M., Bleavins, M. R., and Felix, A., Pharmacogenetic application in drug development and clinical trials. Drug Metab. Dispos. 29(4):591–595, 2001.PubMed

10.

Roper, N., Storer, B., Bona, R., and Fang, M., Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testing. J. Mol. Diagn. 12(3):283–291, 2010.CrossRefPubMedPubMedCentral

11.

Wang, M., Lang, X., Cui, S., Fei, K., Zou, L., Cao, J., Wang, Y., et al., Clinical application of pharmacogenetic-based warfarin-dosing algorithm in patients of Han nationality after rheumatic valve replacement: A randomized and controlled trial. Int. J. Med. Sci. 9(6):472, 2012.CrossRefPubMedPubMedCentral

12.

Feldman, E. A., The Genetic Information Nondiscrimination Act (GINA): Public policy and medical practice in the age of personalized medicine. J. Gen. Intern. Med. 27(6):743–746, 2012.CrossRefPubMedPubMedCentral

13.

Whirl-Carrillo, M., McDonagh, E. M., Hebert, J. M., Gong, L., Sangkuhl, K., Thorn, C. F., Klein, T. E., et al., Pharmacogenomics knowledge for personalized medicine. Clin. Pharmacol. Ther. 92(4):414, 2012.CrossRefPubMedPubMedCentral

14.

Hernandez-Boussard, T., Whirl-Carrillo, M., Hebert, J. M., Gong, L., Owen, R., Gong, M., … and Woon, M., The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge. Nucleic Acids Res. 36(suppl 1)D913–D918, 2008.

15.

O’Donnell, P. H., Bush, A., Spitz, J., Danahey, K., Saner, D., Das, S., Ratain, M. J., et al., The 1200 patients project: Creating a new medical model system for clinical implementation of pharmacogenomics. Clin. Pharmacol. Ther. 92(4):446–449, 2012.CrossRefPubMedPubMedCentral

16.

Johnson, J. A., Cavallari, L. H., Beitelshees, A. L., Lewis, J. P., Shuldiner, A. R., and Roden, D. M., Pharmacogenomics: Application to the management of cardiovascular disease. Clin. Pharmacol. Ther. 90(4):519–531, 2011.CrossRefPubMedPubMedCentral

17.

Gottesman, O., Kuivaniemi, H., Tromp, G., Faucett, W. A., Li, R., Manolio, T. A., Brilliant, M., et al., The electronic medical records and genomics (eMERGE) network: Past, present, and future. Gen. Med. 15(10):761–771, 2013.

18.

Schildcrout, J. S., Denny, J. C., Bowton, E., Gregg, W., Pulley, J. M., Basford, M. A., Ritchie, M. D., et al., Optimizing drug outcomes through pharmacogenetics: A case for preemptive genotyping. Clin. Pharmacol. Ther. 92(2):235–242, 2012.CrossRefPubMedPubMedCentral

19.

Pulley, J. M., Denny, J. C., Peterson, J. F., Bernard, G. R., Vnencak‐Jones, C. L., Ramirez, A. H., Crawford, D. C., et al., Operational implementation of prospective genotyping for personalized medicine: The design of the Vanderbilt PREDICT project. Clin. Pharmacol. Ther. 92(1):87–95, 2012.CrossRefPubMedPubMedCentral

20.

Goldspiel, B. R., Flegel, W. A., DiPatrizio, G., Sissung, T., Adams, S. D., Penzak, S. R., Figg, W. D., et al., Integrating pharmacogenetic information and clinical decision support into the electronic health record. J. Am. Med. Inform. Assoc. 21(3):522–528, 2014.CrossRefPubMed

21.

Overby, C., Tarczy-Hornoch, P., Hoath, J. I., Kalet, I. J., and Veenstra, D. L., Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support. BMC Bioinf. 11(Suppl 9), 2010. doi:10.1186/1471-2105-11-s9-s10

22.

Shabo, A., Meaningful use of pharmacogenomics in health records: Semantics should be made explicit. Pharmacogenomics 11(1):81–87, 2010.CrossRef

23.

Shabo, A., Streamlining genetic testing by standardizing its report formats and exchange among all stakeholders. EPMA J. 5(Suppl 1), 2014. doi:10.1186/1878-5085-5-s1-a61

24.

Peterson, J. F., Bowton, E., Field, J. R., Beller, M., Mitchell, J., Schildcrout, J., Pulley, J. M., et al., Electronic health record design and implementation for pharmacogenomics: A local perspective. Genet. Med. 15(10):833–841, 2013.CrossRefPubMedPubMedCentral

25.

Shirts, B. H., Salama, J. S., Aronson, S. J., Chung, W. K., Gray, S. W., Hindorff, L. A., Van Allen, E. M., et.al., CSER and eMERGE: current and potential state of the display of genetic information in the electronic health record. J. Am. Med. Inform. Assoc. ocv065.

26.

Bell, G. C., Crews, K. R., Wilkinson, M. R., Haidar, C. E., Hicks, J. K., Baker, D. K., … Hoffman, J. M., Development and use of active clinical decision support for preemptive pharmacogenomics. J. Am. Med. Inform. Assoc. 21(E1), 2014. doi:10.1136/amiajnl-2013-001993

27.

Sauver, J. L., Bielinski, S. J., Olson, J. E., Bell, E. J., Gree, M. E., Jacobson, D. J., and Vitek, C. R., Integrating pharmacogenomics into clinical practice: Promise vs reality. Am. J. Med. 129(10):193–199, 2016.CrossRef

28.

Masys, D. R., Jarvik, G. P., Abernethy, N. F., Anderson, N. R., Papanicolaou, G. J., Paltoo, D. N., Levy, H. P., et al., Technical desiderata for the integration of genomic data into electronic health records. J. Biomed. Inform. 45(3):419–422, 2012.CrossRefPubMed

29.

Devine, E. B., Lee, C. J., Overby, C. L., Abernethy, N., McCune, J., Smith, J. W., and Tarczy-Hornoch, P., Usability evaluation of pharmacogenomics clinical decision support aids and clinical knowledge resources in a computerized provider order entry system: A mixed methods approach. Int. J. Med. Inform. 83(7):473–483, 2014.CrossRefPubMedPubMedCentral

30.

Peterson, J. F., Field, J. R., Shi, Y., Schildcrout, J. S., Denny, J. C., Mcgregor, T. L., Clayton, E. W., et al., Attitudes of clinicians following large-scale pharmacogenomics implementation. Pharm. J. 16(4):393–398, 2015.

31.

Ury, A. G., Storing and interpreting genomic information in widely deployed electronic health record systems. Genet. Med. 15(10):779–785, 2013.CrossRefPubMed

32.

Squassina, A., Manchia, M., Manolopoulos, V. G., Artac, M., Lappa-Manakou, C., Karkabouna, S., Patrinos, G. P., et al., Realities and expectations of pharmacogenomics and personalized medicine: Impact of translating genetic knowledge into clinical practice. Pharmacogenomics 11(8):1149–1167, 2010.CrossRefPubMed

Titel: Incorporating Pharmacogenomics into Health Information Technology, Electronic Health Record and Decision Support System: An Overview
verfasst von: Abdullah Alanazi
Publikationsdatum: 01.02.2017
Verlag: Springer US
Erschienen in: Journal of Medical Systems / Ausgabe 2/2017
Print ISSN: 0148-5598
Elektronische ISSN: 1573-689X
DOI: https://doi.org/10.1007/s10916-016-0673-4

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Incorporating Pharmacogenomics into Health Information Technology, Electronic Health Record and Decision Support System: An Overview

Abstract

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2017

Runtime Verification of Pacemaker Functionality Using Hierarchical Fuzzy Colored Petri-nets

Literature Review of Patient Record Structures from the Physician’s Perspective

Smart Sensor-Based Motion Detection System for Hand Movement Training in Open Surgery

An Evolving Ecosystem for Natural Language Processing in Department of Veterans Affairs

Medical Image Retrieval Using Vector Quantization and Fuzzy S-tree

Innovative Power of Health Care Organisations Affects IT Adoption: A bi-National Health IT Benchmark Comparing Austria and Germany